{"schema_version":"secwatch.filing_event.v1","accession":"0001553350-26-000093","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2026-06-18T20:30:18+00:00","discovered_at":"2026-06-18T20:31:00.232492+00:00","generated_at":"2026-06-18T20:35:20.639060+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"TOI stockholders elect all eight director nominees, ratify auditor, approve say-on-pay at 2026 annual meeting","bullets":["Elected eight directors: Brad Hively, Karen Johnson, Mohit Kaushal, Anne McGeorge, Mark Pacala, Mark Stolper, Kimberly Tzoumakas, Daniel Virnich.","Ratified BDO USA, P.C. as independent auditor for FY 2026 with 75,098,890 votes for, 37,257 against.","Say-on-pay approved with 25,280,934 for, 282,655 against, 12,126 abstain.","Advisory vote on executive compensation frequency: annual preferred with 24,918,766 votes (1-year)."],"urls":{"canonical":"https://secwatch.observer/filing/0001553350-26-000093","json":"https://secwatch.observer/filing/0001553350-26-000093.json","markdown":"https://secwatch.observer/filing/0001553350-26-000093.md","text":"https://secwatch.observer/filing/0001553350-26-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T20:35:20.639060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0353f9f776dddd1b0eca0eb4d58de1f4a766ef1c","claim":"Oncology Institute, Inc. shareholders approved Approval, on a non-binding, advisory basis, of the preferred frequency of future advisory votes on the compensation of the Company’s named executive officers (the “Say-on-Frequency Proposal”) at the 2026-06-17 meeting.","evidence_excerpt":"The Say-on-Frequency Proposal was approved","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"3aa5fd149b4286644459fd4705b449dfca029fcf","claim":"Oncology Institute, Inc. shareholders approved Approval, on a non-binding, advisory basis, of the Company’s named executive officers (the “Say-on-Pay Proposal”) at the 2026-06-17 meeting.","evidence_excerpt":"The Say-on-Pay Proposal was approved.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"84185ca18cb4038bf38051ef1b8b66ecbda82da7","claim":"Oncology Institute, Inc. shareholders approved Election of eight directors at the 2026-06-17 meeting.","evidence_excerpt":"The Company’s stockholders elected eight directors to serve for the ensuing year and until their successors are elected and qualified, or until their earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"a0be693648ef74d0dbdf67f8bc0b3ab9ba688dba","claim":"Oncology Institute, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accountants at the 2026-06-17 meeting.","evidence_excerpt":"The ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335026000093/0001553350-26-000093-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}